Transcription status of vaccine candidate genes of Plasmodium falciparum during the hepatic phase of its life cycle.
D000818:Animals; D000953:Antigens, Protozoan / Q000235:genetics* / Q000502:physiology; D020869:Gene Expression Profiling; D017125:Genes, Protozoan; D022781:Hepatocytes / Q000469:parasitology*; D017780:Malaria Vaccines; D008565:Membrane Proteins / Q000235:genetics; D010963:Plasmodium falciparum / Q000235:genetics* / Q000254:growth & development; D015800:Protozoan Proteins / Q000235:genetics* / Q000502:physiology; D012333:RNA, Messenger / Q000032:analysis / Q000302:isolation & purification; D020133:Reverse Transcriptase Polymerase Chain Reaction
D000953:Antigens, Protozoan; C079081:MESA protein, Plasmodium falciparum; D017780:Malaria Vaccines; D008565:Membrane Proteins; D015800:Protozoan Proteins; D012333:RNA, Messenger; C041595:circumsporozoite protein, Protozoan; C065974:merozoite surface protein 2, Plasmodium; C089133:merozoite surface protein 3, Plasmodium; C114957:merozoite surface protein 5; C065352:rhoptry associated protein, Plasmodium; C050256:ring-infected erythrocyte surface antigen (RESA), Plasmodium falciparum; C057495:serine repeat antigen, Plasmodium; C069428:thrombospondin-related adhesive protein, protozoan; C073168:rhoptry-associated antigen-2, Plasmodium